← FDA Drug Approvals (Drugs@FDA)

TOPIRAMATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS · Approved 2023-12-05

Drug application

FDA Application #

ANDA217694

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOPIRAMATE

Generic name

TOPIRAMATE

Active ingredients

TOPIRAMATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TWI PHARMS

Manufacturer

Upsher-Smith Laboratories, LLC

First approval

2023-12-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown